Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Isabella Montagna
Observed names:
I Montagna,
I. Montagna
Institution:
Chiesi (Italy)
Observed institution:
Chiesi (Italy)
OpenAlex ID:
A5015381171
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
2018
·
Alberto Papi
, Jørgen Vestbo
, et al.
·
The Lancet
·
620
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
2017
·
Jørgen Vestbo
, Alberto Papi
, et al.
·
The Lancet
·
433
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
2016
·
Dave Singh
, Alberto Papi
, et al.
·
The Lancet
·
431
PDF
Artificial intelligence based software facilitates spirometry quality control in asthma and COPD clinical trials
2022
·
Eva Topole
, Sonia Biondaro
, et al.
·
ERJ Open Research
·
35
PDF
Opportunities in Development of Patient-Centric and Decentralized Clinical Trials: Insights from Patients and Healthcare Professionals in Respiratory and Rare Diseases
2025
·
Marisa Minetti
, Eva Topole
, et al.
·
Therapeutic Innovation & Regulatory Science
·
4
PDF
ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials
2021
·
Eva Topole
, Sonia Biondaro
, et al.
·
European Respiratory Journal
·
2
AI Over-reading Based on ATS/ERS 2019 Criteria Is a Reliable Option for Instant Spirometry Quality Control in Clinical Trials
2023
·
B. Cuyvers
, P. Desbordes
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
A tool to facilitate spirometry quality control assessment using 2019 standards
2022
·
B Graham
, S Stanojevic
, et al.
·
European Respiratory Journal
·
1
Artificial Intelligence Assists in Quality Assessment of Spirometry in Clinical Trials
2021
·
E. Topole
, S. Biondaro
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies.
2018
·
Leonardo Fabbri
, Dave Singh
, et al.
·
European Respiratory Journal
·
1
Extrafine beclometasone dipropionate, formoterol fumarate, glycopyrronium (BDP/FF/G) and exacerbation recurrence: post-hoc analysis of the TRIBUTE study.
2018
·
Leonardo Fabbri
, Dave Singh
, et al.
·
European Respiratory Journal
·
1
P276 Cardiovascular safety of extrafine single inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide in copd: results of safety analysis from the trilogy and trinity studies
2017
·
M Scuri
, D Singh
, et al.
·
Thorax
·
1
PDF
P273 Association of incident pneumonia and exacerbations with extrafine triple therapy in one single inhaler in copd patients: a post-hoc analysis from trilogy and trinity studies
2017
·
M Scuri
, J Vestbo
, et al.
·
Thorax
·
1
PDF
P271 Effect of extrafine single inhaler triple therapy on lung function and use of rescue medication: results from the trinity study
2017
·
M Scuri
, J Vestbo
, et al.
·
Thorax
·
1
PDF
LATE-BREAKING ABSTRACT: Association of incident pneumonia and exacerbations with extrafine beclometasone dipropionate/formoterol (BDP/FF) in severe COPD patients: A post-hoc analysis of FORWARD study
2016
·
Massimo Corradi
, Monica Spinola
, et al.
·
European Respiratory Journal
·
1
Efficacy and safety of extrafine glycopyrronium bromide pMDI (CHF 5259) in COPD patients
2016
·
Elzbieta Hajol
, Annalisa Piccinno
, et al.
·
European Respiratory Journal
·
1
Is Onsite Spirometry Quality Predicting the Quality of Home Spirometry?
2024
·
B. Cuyvers
, P. Desbordes
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Impact of Artificial Intelligence Over-Reading for Instant Feedback on Quality of Home Spirometry
2023
·
B. Cuyvers
, P. Desbordes
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Impact on spirometry quality results when using 2005 or 2019 ATS/ERS guidelines
2021
·
Eva Topole
, Sonia Biondaro
, et al.
·
European Respiratory Journal
Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: Results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies
2019
·
LM Fabbri
, D Singh
, et al.
·
Pneumologie
Association of Incident Pneumonia and Exacerbations with Extrafine Triple Therapy in One Single Inhaler in COPD
2018
·
M Scuri
, J Vestbo
, et al.
·
Pneumologie
Tolérance cardiovasculaire de la triple association fixe en particules extra-fines (béclométasone – DPB, formotérol – FF et glycopyrronium – GB – TRIMBOW ® ) dans la BPCO : résultats d’une analyse de tolérance des études TRILOGY et TRINITY
2018
·
M. Scuri
, D. Singh
, et al.
·
Revue des Maladies Respiratoires
Comparaison de l’incidence des pneumonies et des exacerbations chez des patients BPCO traités par une triple association fixe : analyse post-hoc des études TRILOGY et TRINITY
2018
·
M. Scuri
, J. Vestbo
, et al.
·
Revue des Maladies Respiratoires
Effets de la triple thérapie fixe en particules extra-fines (TRIMBOW ® spray) en sur la fonction pulmonaire de patients BPCO : résultats de l’analyse des répondeurs de l’étude TRINITY
2018
·
M. Scuri
, J. Vestbo
, et al.
·
Revue des Maladies Respiratoires
La triple thérapie fixe en particules extra-fines (Trimbow ® spray) réduit le recours au traitement de secours chez les patients BPCO : résultats de l’étude TRINITY
2018
·
M. Scuri
, D. Singh
, et al.
·
Revue des Maladies Respiratoires
Show more works
View as search
Works count:
29
Citation count:
1,535
H-index:
4
I10-index:
4
Year
Topic
Type
